Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti-VEGF Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01591109
What this trial is testing

A Reversal in the Vascularity of Metastatic Liver Tumors From Colorectal Cancer After the Cessation of Anti-VEGF Therapy

Who this might be right for
Colorectal Cancer
NHO - Matsumoto Medical Center 20
Not applicableUnknownNCT01310686
What this trial is testing

Genetics Study of Wet Age-Related Macular Degeneration (AMD) Non-Responders to Vascular Endothelial Growth Factor (VEGF) Therapy

Who this might be right for
Wet AMD
West Coast Retina Medical Group, Inc. 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT05756972
What this trial is testing

PM8002 (Anti-PD-L1/VEGF) in Combination With Chemotherapy in Patients With NSCLC

Who this might be right for
NSCLC
Biotheus Inc. 64
Not applicableNot Yet RecruitingNCT07328776
What this trial is testing

AI vs. Physician for Anti-VEGF Decision-Making: An RCT

Who this might be right for
DMERetinal Vein Occlusion (RVO)Neovascular (Wet) Age-Related Macular Degeneration
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 200
Testing effectiveness (Phase 2)Study completedNCT04172571
What this trial is testing

The Combination of Anti-PD-1 AK105 and Anlotinib in First-line Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
Akeso 31
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07064902
What this trial is testing

Ivonescimab Combined With Chemoradiotherapy in High-Risk Locoregionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma (NPC)
Sun Yat-sen University 48
Post-approval studies (Phase 4)UnknownNCT04380974
What this trial is testing

Efficacy and Safety of Two Regimens of Anti-VEGF Therapy in Chinese Patients With Polypoidal Choroidal Vasculopathy

Who this might be right for
Polypoidal Choroidal Vasculopathy
Xiaodong Sun 102
Not applicableStudy completedNCT04241198
What this trial is testing

Home Retinal Imaging Using NOTAL-OCT V3.0

Who this might be right for
A. AMD Patients, Where at Least One Eye is With Active CNV, Presenting Retinal Fluid at the Enrolment Visit, Undergoing Active Anti-VEGF Treatment
Notal Vision Ltd. 10
Post-approval studies (Phase 4)Ended earlyNCT05473715
What this trial is testing

Learn How Well Aflibercept Injected Into the Eye Works and How Safe it is When Given in Customized Treatment Intervals in Patients With an Eye Disease Called Neovascular Age-related Macular Degeneration After Start of Treatment

Who this might be right for
Neovascular (Wet) Age-related Macular Degeneration
Bayer 3
Testing effectiveness (Phase 2)Study completedNCT00016549
What this trial is testing

Bevacizumab to Treat Inflammatory Breast Cancer or Locally Advanced Breast Cancer

Who this might be right for
Breast Cancer
National Cancer Institute (NCI) 21
Not applicableUnknownNCT05759884
What this trial is testing

Efficacy Analysis of Anti-VEGF Drugs Combined With Micropulse Laser in the Treatment of Diabetic Macular Edema

Who this might be right for
Macular Edema Due to Type 2 Diabetes Mellitus
Second Affiliated Hospital, Zhejiang University, School of Medicine 40
Early research (Phase 1)Study completedNCT05116007
What this trial is testing

Anti-PD-1 and VEGF Bispecific Antibody AK112 in Combination With Chemotherapy in Patients With ES-SCLC

Who this might be right for
SCLC, Extensive Stage
Akeso 35
Early research (Phase 1)UnknownNCT00652119
What this trial is testing

Intraperitoneal Paclitaxel and Carboplatin With IV Avastin Therapy in Patients With Carcinomas of Mullerian Origin

Who this might be right for
Ovarian CancerPeritoneal CancerFallopian Tube Cancer
Massachusetts General Hospital 46
Not applicableStudy completedNCT03065907
What this trial is testing

Timing of Low Vision Rehabilitation in Anti- Vascular Endothelial Growth Factor (VEGF) Therapy

Who this might be right for
Low VisionNeovascular Age-related Macular Degeneration
Johns Hopkins University 3
Large-scale testing (Phase 3)Not Yet RecruitingNCT07520318
What this trial is testing

This is a 96-week, Multicenter Study in Patients With Neovascular AMD That Evaluates OCUL101 for Efficacy, Safety, Durability, and Pharmacokinetics, Comparing it With Another Treatment. The Study Will be Conducted in Two Parts, Part A and Part B.

Who this might be right for
Adults With Neovascular Age-related Macular Degeneration
Shenzhen Oculgen Biomedical Technology Co., Ltd. 255
Not applicableStudy completedNCT01914380
What this trial is testing

Investigating the Effectiveness of Eylea in Patients With Wet Age-related Macular Degeneration

Who this might be right for
Wet Age-related Macular Degeneration
Bayer 988
Testing effectiveness (Phase 2)Ended earlyNCT02387957
What this trial is testing

A 24 Month Phase 2a Open Label, Randomized Study of Avastin®, Lucentis®, or Eylea® (Anti-VEGF Therapy) Administered in Combination With Fovista® (Anti-PDGF BB Pegylated Aptamer)

Who this might be right for
Age-Related Macular Degeneration
Ophthotech Corporation 63
Not applicableUnknownNCT05222633
What this trial is testing

Anti-VEGF in Real-world

Who this might be right for
Neovascular Age-related Macular EdemaDiabetic Macular EdemaChoroidal Neovascular Membrane+3 more
Wenbin Wei 1,000
Large-scale testing (Phase 3)Study completedNCT01976338
What this trial is testing

Ranibizumab Intravitreal Injections Versus Sham Control in Patients With Branch Retinal Vein Occlusion (BRVO)

Who this might be right for
Macular Edema Secondary to Branch Retinal Vein Occlusion
Novartis Pharmaceuticals 283
Not applicableStudy completedNCT02279537
What this trial is testing

Real Life of Aflibercept In FraNce: oBservatiOnnal Study in Wet AMD

Who this might be right for
Wet Macular Degeneration
Bayer 593
Next Page